As the global response to COVID-19 shifts from emergency to endurance, the virus continues to evolve. India’s detection of new sub-variants illustrates that pathogenic drift persists quietly beneath immunological surveillance. In this context, disease mitigation strategies must expand beyond pharmaceutical interventions toward approaches that are sustainable, scalable, and biologically synergistic. In this evolving paradigm, Moringa oleifera is being reevaluated—not as folk wisdom for its nutrient richness, but as a botanical asset with evidence-based bioactivity and therapeutic potential.
